肠道菌群
2型糖尿病
糖尿病
胰岛素敏感性
肠道微生物群
微生物群
医学
碳水化合物代谢
生物
生物信息学
胰岛素抵抗
内分泌学
免疫学
标识
DOI:10.1016/j.sjbs.2021.04.041
摘要
Diabetes is an emerging health condition globally and is suggested to have a direct connection with the gut microbiota that determine our metabolic outcomes. Sensitivity to insulin and glucose metabolism is normal in healthy people as compared to those people who cannot maintain their glucose metabolism. One of the reasons of the differences is that healthy people have different microbiome that leads to achieve more short chain fatty acids and make up more branched amino acids, while the gut microbiota of the other group of people are more likely to produce compounds that affects glucose metabolism. Herein, this review will present the research related to the impact of gut microbes on diabetes carried out in the past decade. The review focus on the relation between gut microbiota and Type-1 Diabetes (T1D), Type-2 Diabetes (T2D), and how gut microbiota could be an alternative therapy for treatment of diabetes.
科研通智能强力驱动
Strongly Powered by AbleSci AI